PUBLIC COMPANY
saveCURIUM
USupdated 2mo ago
community read0 votes
pipeline
9
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(9)
pipeline depth9 products
9Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Curium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing case☢️ Curium spends $8B for Lantheus: Curium is buying fellow radiopharma company Lantheus for $102.5 per share. Lantheus shareholders may receive $12 more per share if certain targets are achieved ...endpoints · 10h ago
- Supernus and Indivior merge to create CNS mega-company with 11 approved drugsSupernus Pharmaceuticals and Indivior Pharmaceuticals are outlining a combined expected $2.2 billion in annual revenue, plus $125 million in cost savings that will include “natural redundancies.”biospace · 11h ago
- Curium strikes up to $8B deal for radiopharma rival LantheusMonths after reports first linked Curium to a potential Lantheus takeover, the radiopharma players have made it official with a deal worth up to $8 billion.fiercebiotech · 11h ago
- Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drugPlus, news about West Pharmaceutical, Stallergenes Greer and Curium: 🏭 Hikma’s US expansion: The generic drugmaker is investing $267 million in Ohio. Its existing factory in Columbus will get $216…endpoints · 2mo ago
comments(0)
5-min edit window · permanent after that